Saflufenacil Market Report, Global Industry Analysis, Market Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2023 - 2030

  • Published Date: Jan, 2024
  • Report ID: CR0185564
  • Format: Electronic (PDF)
  • Number of Pages: 184
  • Author(s): Joshi, Madhavi

Report Overview

The Saflufenacil Market size was estimated at USD 180 million in 2023 and is projected to reach USD 350 million by 2030, exhibiting a compound annual growth rate (CAGR) of 9.00% during the forecast period (2024-2030).

Saflufenacil Market

(Market Size)
$180 million
$350 million
2023
2030
Source: Citius Research
Study Period 2018 - 2030
Base Year For Estimation 2023
Forecast Data Period 2024 - 2030
CAGR (2024-2030) 9.00%
2023 Market Size USD 180 million
2030 Market Size USD 350 million
Key Players BASF, Bayer, Syngenta, Corteva, FMC Corporation

Market Summary

The Saflufenacil market is a specialized segment within the global agricultural chemicals industry, focusing on a herbicide known for its pre-emergent and post-emergent control of broadleaf weeds. Saflufenacil is a protoporphyrinogen oxidase (PPO) inhibitor herbicide, valued for its rapid action and effectiveness in various cropping systems. It is primarily utilized in key agricultural regions where high-value crops are cultivated and weed resistance management is a critical concern for farmers. The market is characterized by its integration into modern integrated weed management programs, offering a solution for controlling difficult and resistant weed species. Demand is driven by the necessity for effective herbicide solutions that support high agricultural productivity and sustainability. The market involves a network of manufacturers, formulators, distributors, and end-user farmers, with products available in various formulations to suit different application needs. Regulatory approvals and environmental considerations play a significant role in market dynamics, influencing product availability and usage patterns across different geographies.

Key Highlights

Saflufenacil is distinguished by its unique mode of action as a PPO inhibitor, which provides rapid burndown of a wide spectrum of broadleaf weeds. A key highlight is its utility in resistance management strategies, helping to combat weeds that have developed resistance to other herbicide classes such as glyphosate. It is often used in pre-plant burndown and pre-emergence applications in crops like soybeans, corn, and cereals, offering flexibility and reliability. The herbicide is noted for its favorable environmental profile, including low use rates and reduced soil persistence compared to some older chemistries, which aligns with growing demands for sustainable agricultural practices. Major agricultural chemical companies, including BASF SE, have developed and commercialized saflufenacil-based products, underscoring its importance in the crop protection portfolio. Its adoption is particularly significant in regions battling tough weeds like Palmer amaranth and waterhemp, making it a critical tool for maintaining crop yields and farm profitability.

Drivers, Opportunities & Restraints

The primary drivers of the Saflufenacil market include the increasing prevalence of herbicide-resistant weeds, which compels farmers to adopt alternative chemical solutions with different modes of action. The growing global demand for food and the consequent intensification of agricultural practices further propel the need for effective weed control products. Opportunities in the market are evident in the expansion into new geographical regions and the development of novel formulations and premixes that enhance efficacy and user safety. There is also potential for increased adoption in additional crop types and integrated pest management programs. However, the market faces restraints such as stringent regulatory hurdles and the lengthy approval processes for new agricultural chemicals, which can delay market entry and expansion. Environmental concerns and the potential for off-target movement or drift also pose challenges, necessitating careful application and stewardship. Additionally, the high cost of research and development for new products can be a barrier for smaller players in the market.

Concentration Insights

The Saflufenacil market exhibits a concentrated structure, with a limited number of key players dominating production and distribution. BASF SE is a leading entity, having originally developed and introduced saflufenacil to the market under various brand names. Other significant companies include manufacturers of generic agrochemicals who produce saflufenacil-based formulations following patent expirations, though innovation and new product development remain concentrated among larger firms with extensive R&D capabilities. The market concentration is influenced by high barriers to entry, including substantial capital investment required for chemical synthesis, regulatory compliance, and the establishment of distribution networks. Collaborations and partnerships between multinational corporations and local distributors are common strategies to enhance market penetration in different regions. This concentration ensures that product quality and regulatory standards are maintained but can also limit competitive pricing and innovation from smaller entrants.

Type Insights

Saflufenacil is commercially available in several formulation types to cater to diverse application requirements and farmer preferences. The most common formulations include wettable granules (WG) and dispersible concentrates (DC), which are designed for easy mixing and application in water. These formulations are engineered to optimize the herbicide's solubility, stability, and efficacy upon application. The choice of formulation depends on factors such as the target weed spectrum, crop stage, and application equipment. Some products are offered as premixes with other herbicides, such as glyphosate or imazethapyr, to broaden the spectrum of control and manage resistance more effectively. The development of advanced formulations aims to improve user safety, reduce environmental impact, and enhance overall performance in the field.

Application Insights

Saflufenacil is applied in various agricultural settings, primarily for pre-plant burndown and pre-emergence weed control in row crops. Its major application is in soybean production, where it is used to manage broadleaf weeds before crop emergence, providing a clean seedbed. It is also utilized in corn, cereals, and pastures, demonstrating versatility across different cropping systems. In addition to agricultural uses, saflufenacil finds applications in non-crop areas such as industrial vegetation management, where control of persistent weeds is necessary. The herbicide is valued for its ability to control resistant weeds, including those resistant to ALS inhibitors and glyphosate, making it an integral component of modern weed management programs. Application timing and method are critical for maximizing efficacy and minimizing potential crop injury, with recommendations typically provided based on extensive field trials.

Regional Insights

The adoption and usage of Saflufenacil vary significantly across different regions, influenced by agricultural practices, weed pressure, and regulatory frameworks. North America, particularly the United States, represents a major market due to high incidences of herbicide-resistant weeds in key crops like soybeans and corn. South America, with its extensive soybean cultivation in countries like Brazil and Argentina, is another significant region where saflufenacil is increasingly adopted. Europe has a more regulated environment, with usage dependent on approval status in individual countries, often focused on specific crops and conditions. The Asia-Pacific region shows growing potential, especially in countries with expanding agricultural sectors, though adoption may be slower due to regulatory processes and different farming practices. Each region presents unique challenges and opportunities, shaped by local agronomic needs and environmental policies.

Company Insights

BASF SE is the pioneering company behind saflufenacil, having developed and launched it as part of their herbicide portfolio. The company offers products such as Kixor herbicide technology, which incorporates saflufenacil. Other notable companies involved in the market include manufacturers of generic agrochemicals who produce saflufenacil after the expiration of relevant patents. These companies often operate through partnerships or licensing agreements to ensure compliance with regulatory standards. Key players focus on continuous research to improve formulations and expand label claims for use in additional crops and regions. The competitive landscape is characterized by efforts to provide integrated solutions that combine saflufenacil with other herbicides to address complex weed management challenges effectively.

Recent Developments

Recent developments in the Saflufenacil market include the introduction of new formulated products and premixes that enhance weed control spectrum and application flexibility. Regulatory approvals for expanded use in additional countries and crops have been a focus, allowing greater market access. Companies are investing in research to improve formulation technologies, aiming to increase efficacy and reduce environmental impact. There has been a trend towards developing combination products that include saflufenacil with other herbicides to combat multiple resistance mechanisms and simplify application for farmers. Stewardship programs and educational initiatives have been emphasized to promote responsible use and minimize risks of off-target movement. These developments reflect the ongoing innovation and adaptation within the market to meet evolving agricultural needs.

Report Segmentation

This market report on Saflufenacil provides a detailed segmentation to offer comprehensive insights. The segmentation is based on type, categorizing the market into different formulation types such as wettable granules and dispersible concentrates. Application segmentation covers its use in various sectors including agriculture?further broken down into crops like soybeans, corn, and cereals?and non-agricultural uses such as industrial vegetation management. Regional segmentation analysis divides the market into key geographical areas including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, each examined for market dynamics, adoption rates, and growth potential. This structured approach allows for a thorough understanding of market trends, demand patterns, and competitive landscape across different segments and regions.

FAQs

What is Saflufenacil used for? Saflufenacil is a herbicide used primarily for controlling broadleaf weeds in agricultural crops such as soybeans, corn, and cereals. It is effective for pre-plant burndown and pre-emergence applications.

How does Saflufenacil work? Saflufenacil works by inhibiting the protoporphyrinogen oxidase (PPO) enzyme in plants, which disrupts chlorophyll production and leads to rapid desiccation and death of susceptible weeds.

Is Saflufenacil safe for crops? When used according to label directions, saflufenacil is selective and safe for certain crops, but it requires careful application timing and practices to avoid potential crop injury.

What weeds does Saflufenacil control? Saflufenacil controls a wide range of broadleaf weeds, including resistant species like Palmer amaranth, waterhemp, and ragweed.

Can Saflufenacil be mixed with other herbicides? Yes, saflufenacil is often formulated as a premix or tank-mixed with other herbicides such as glyphosate to broaden the weed control spectrum and manage resistance.

Citius Research has developed a research report titled “Saflufenacil Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” delivering key insights regarding business intelligence and providing concrete business strategies to clients in the form of a detailed syndicated report. The report details out the factors such as business environment, industry trend, growth opportunities, competition, pricing, global and regional market analysis, and other market related factors.

Details included in the report for the years 2024 through 2030

• Saflufenacil Market Potential
• Segment-wise breakup
• Compounded annual growth rate (CAGR) for the next 6 years
• Key customers and their preferences
• Market share of major players and their competitive strength
• Existing competition in the market
• Price trend analysis
• Key trend analysis
• Market entry strategies
• Market opportunity insights

The report focuses on the drivers, restraints, opportunities, and challenges in the market based on various factors geographically. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The Saflufenacil Market report is segmented on the basis of various market segments and their analysis, both in terms of value and volume, for each region for the period under consideration.

Saflufenacil Market Segmentation

Market Segmentation

Regions Covered

• North America
• Latin America
• Europe
• MENA
• Asia Pacific
• Sub-Saharan Africa and
• Australasia

Saflufenacil Market Analysis

The report covers below mentioned analysis, but is not limited to:

• Overview of Saflufenacil Market
• Research Methodology
• Executive Summary
• Market Dynamics of Saflufenacil Market
  • Driving Factors
  • Restraints
  • Opportunities
• Global Market Status and Forecast by Segment A
• Global Market Status and Forecast by Segment B
• Global Market Status and Forecast by Segment C
• Global Market Status and Forecast by Regions
• Upstream and Downstream Market Analysis of Saflufenacil Market
• Cost and Gross Margin Analysis of Saflufenacil Market
• Saflufenacil Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030
  • Competition Landscape
  • Market Share of Major Players
• Key Recommendations

The “Saflufenacil Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” report helps the clients to take business decisions and to understand strategies of major players in the industry. The report delivers the market driven results supported by a mix of primary and secondary research. The report provides the results triangulated through authentic sources and upon conducting thorough primary interviews with the industry experts. The report includes the results on the areas where the client can focus and create point of parity and develop a competitive edge, based on real-time data results.

Saflufenacil Market Key Stakeholders

Below are the key stakeholders for the Saflufenacil Market:

• Manufacturers
• Distributors/Traders/Wholesalers
• Material/Component Manufacturers
• Industry Associations
• Downstream vendors

Saflufenacil Market Report Scope

Report AttributeDetails
Base year2023
Historical data2018 – 2023
Forecast2024 - 2030
CAGR2024 - 2030
Quantitative UnitsValue (USD Million)
Report coverageRevenue Forecast, Competitive Landscape, Growth Factors, Trends and Strategies. Customized report options available on request
Segments coveredProduct type, technology, application, geography
Regions coveredNorth America, Latin America, Europe, MENA, Asia Pacific, Sub-Saharan Africa and Australasia
Countries coveredUS, UK, China, Japan, Germany, India, France, Brazil, Italy, Canada, Russia, South Korea, Australia, Spain, Mexico and others
Customization scopeAvailable on request
PricingVarious purchase options available as per your research needs. Discounts available on request

COVID-19 Impact Analysis

Like most other markets, the outbreak of COVID-19 had an unfavorable impact on the Saflufenacil Market worldwide. This report discusses in detail the disruptions experienced by the market, the impact on flow of raw materials, manufacturing operations, production trends, consumer demand and the projected future of this market post pandemic.

The report has helped our clients:

• To describe and forecast the Saflufenacil Market size, on the basis of various segmentations and geography, in terms of value and volume
• To measure the changing needs of customers/industries
• To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the market
• To gain competitive intelligence and uncover new opportunities
• To analyse opportunities in the market for stakeholders by identifying high-growth segments in Saflufenacil Market
• To strategically profile key players and provide details of the current competitive landscape
• To analyse strategic approaches adopted by players in the market, such as product launches and developments, acquisitions, collaborations, contracts, expansions, and partnerships

Report Customization

Citius Research provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Customize This Report

Frequently Asked Questions

The Global Saflufenacil Market size was valued at $XX billion in 2023 and is anticipated to reach $XX billion by 2030 growing at a CAGR of XX%
The global Saflufenacil Market is expected to grow at a CAGR of XX% from 2023 to 2030.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.

Table of Contents

Chapter 1. Introduction
  1.1. Market Scope
  1.2. Key Segmentations
  1.3. Research Objective
Chapter 2. Research Methodology & Assumptions
Chapter 3. Executive Summary
Chapter 4. Market Background
  4.1. Dynamics
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunity
    4.1.4. Challenges
  4.2. Key Trends in the Impacting the Market
    4.2.1. Demand & Supply
  4.3. Industry SWOT Analysis
  4.4. Porter’s Five Forces Analysis
  4.5. Value and Supply Chain Analysis
  4.6. Macro-Economic Factors
  4.7. COVID-19 Impact Analysis
    4.7.1. Global and Regional Assessment
  4.8. Profit Margin Analysis
  4.9. Trade Analysis
    4.9.1. Importing Countries
    4.9.2. Exporting Countries
  4.10. Market Entry Strategies
  4.11. Market Assessment (US$ Mn and Units)
Chapter 5. Global Saflufenacil Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment A
  5.1. By Segment A, 2024 - 2030
    5.1.1. Sub-Segment A
    5.1.2. Sub-Segment B
  5.2. Opportunity Analysis
Chapter 6. Global Saflufenacil Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment B
  6.1. By Segment B, 2024 - 2030
    6.1.1. Sub-Segment A
    6.1.2. Sub-Segment B
  6.2. Opportunity Analysis
Chapter 7. Global Saflufenacil Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment C
  7.1. By Segment C, 2024 - 2030
    7.1.1. Sub-Segment A
    7.1.2. Sub-Segment B
  7.2. Opportunity Analysis
Chapter 8. Global Saflufenacil Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Region
  8.1. By Region, 2024 - 2030
    8.1.1. North America
    8.1.2. Latin America
    8.1.3. Europe
    8.1.4. MENA
    8.1.5. Asia Pacific
    8.1.6. Sub-Saharan Africa
    8.1.7. Australasia
  8.2. Opportunity Analysis
Chapter 9. North America Saflufenacil Market Forecast and Trend Analysis
  9.1. Regional Overview
  9.2. Pricing Analysis
  9.3. Key Trends in the Region
    9.3.1. Supply and Demand
  9.4. Demographic Structure
  9.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    9.5.1. Sub-Segment A
    9.5.2. Sub-Segment B
  9.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    9.6.1. Sub-Segment A
    9.6.2. Sub-Segment B
  9.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    9.7.1. Sub-Segment A
    9.7.2. Sub-Segment B
  9.8. By Country, 2024 - 2030, (US$ Mn and Units)
    9.8.1. U.S.
    9.8.2. Canada
    9.8.3. Rest of North America
  9.9. Opportunity Analysis
Chapter 10. Latin America Saflufenacil Market Forecast and Trend Analysis
  10.1. Regional Overview
  10.2. Pricing Analysis
  10.3. Key Trends in the Region
    10.3.1. Supply and Demand
  10.4. Demographic Structure
  10.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    10.5.1. Sub-Segment A
    10.5.2. Sub-Segment B
  10.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    10.6.1. Sub-Segment A
    10.6.2. Sub-Segment B
  10.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    10.7.1. Sub-Segment A
    10.7.2. Sub-Segment B
  10.8. By Country, 2024 - 2030, (US$ Mn and Units)
    10.8.1. Brazil
    10.8.2. Argentina
    10.8.3. Rest of Latin America
  10.9. Opportunity Analysis
Chapter 11. Europe Saflufenacil Market Forecast and Trend Analysis
  11.1. Regional Overview
  11.2. Pricing Analysis
  11.3. Key Trends in the Region
    11.3.1. Supply and Demand
  11.4. Demographic Structure
  11.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    11.5.1. Sub-Segment A
    11.5.2. Sub-Segment B
  11.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    11.6.1. Sub-Segment A
    11.6.2. Sub-Segment B
  11.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    11.7.1. Sub-Segment A
    11.7.2. Sub-Segment B
  11.8. By Country, 2024 - 2030, (US$ Mn and Units)
    11.8.1. UK
    11.8.2. Germany
    11.8.3. France
    11.8.4. Spain
    11.8.5. Rest of Europe
  11.9. Opportunity Analysis
Chapter 12. MENA Saflufenacil Market Forecast and Trend Analysis
  12.1. Regional Overview
  12.2. Pricing Analysis
  12.3. Key Trends in the Region
    12.3.1. Supply and Demand
  12.4. Demographic Structure
  12.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    12.5.1. Sub-Segment A
    12.5.2. Sub-Segment B
  12.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    12.6.1. Sub-Segment A
    12.6.2. Sub-Segment B
  12.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    12.7.1. Sub-Segment A
    12.7.2. Sub-Segment B
  12.8. By Country, 2024 - 2030, (US$ Mn and Units)
    12.8.1. Egypt
    12.8.2. Algeria
    12.8.3. GCC
    12.8.4. Rest of MENA
  12.9. Opportunity Analysis
Chapter 13. Asia Pacific Saflufenacil Market Forecast and Trend Analysis
  13.1. Regional Overview
  13.2. Pricing Analysis
  13.3. Key Trends in the Region
    13.3.1. Supply and Demand
  13.4. Demographic Structure
  13.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    13.5.1. Sub-Segment A
    13.5.2. Sub-Segment B
  13.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    13.6.1. Sub-Segment A
    13.6.2. Sub-Segment B
  13.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    13.7.1. Sub-Segment A
    13.7.2. Sub-Segment B
  13.8. By Country, 2024 - 2030, (US$ Mn and Units)
    13.8.1. India
    13.8.2. China
    13.8.3. Japan
    13.8.4. ASEAN
    13.8.5. Rest of Asia Pacific
  13.9. Opportunity Analysis
Chapter 14. Sub-Saharan Africa Saflufenacil Market Forecast and Trend Analysis
  14.1. Regional Overview
  14.2. Pricing Analysis
  14.3. Key Trends in the Region
    14.3.1. Supply and Demand
  14.4. Demographic Structure
  14.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    14.5.1. Sub-Segment A
    14.5.2. Sub-Segment B
  14.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    14.6.1. Sub-Segment A
    14.6.2. Sub-Segment B
  14.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    14.7.1. Sub-Segment A
    14.7.2. Sub-Segment B
  14.8. By Country, 2024 - 2030, (US$ Mn and Units)
    14.8.1. Ethiopia
    14.8.2. Nigeria
    14.8.3. Rest of Sub-Saharan Africa
  14.9. Opportunity Analysis
Chapter 15. Australasia Saflufenacil Market Forecast and Trend Analysis
  15.1. Regional Overview
  15.2. Pricing Analysis
  15.3. Key Trends in the Region
    15.3.1. Supply and Demand
  15.4. Demographic Structure
  15.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    15.5.1. Sub-Segment A
    15.5.2. Sub-Segment B
  15.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    15.6.1. Sub-Segment A
    15.6.2. Sub-Segment B
  15.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    15.7.1. Sub-Segment A
    15.7.2. Sub-Segment B
  15.8. By Country, 2024 - 2030, (US$ Mn and Units)
    15.8.1. Australia
    15.8.2. New Zealand
    15.8.3. Rest of Australasia
  15.9. Opportunity Analysis
Chapter 16. Competition Analysis
  16.1. Competitive Benchmarking
    16.1.1. Top Player’s Market Share
    16.1.2. Price and Product Comparison
  16.2. Company Profiles
    16.2.1. Company A
      16.2.1.1. Company Overview
      16.2.1.2. Segmental Revenue
      16.2.1.3. Product Portfolio
      16.2.1.4. Key Developments
      16.2.1.5. Strategic Outlook
    16.2.2. Company B
      16.2.2.1. Company Overview
      16.2.2.2. Segmental Revenue
      16.2.2.3. Product Portfolio
      16.2.2.4. Key Developments
      16.2.2.5. Strategic Outlook
    16.2.3. Company C
      16.2.3.1. Company Overview
      16.2.3.2. Segmental Revenue
      16.2.3.3. Product Portfolio
      16.2.3.4. Key Developments
      16.2.3.5. Strategic Outlook
    16.2.4. Company D
      16.2.4.1. Company Overview
      16.2.4.2. Segmental Revenue
      16.2.4.3. Product Portfolio
      16.2.4.4. Key Developments
      16.2.4.5. Strategic Outlook
    16.2.5. Company E
      16.2.5.1. Company Overview
      16.2.5.2. Segmental Revenue
      16.2.5.3. Product Portfolio
      16.2.5.4. Key Developments
      16.2.5.5. Strategic Outlook
    16.2.6. Company F
      16.2.6.1. Company Overview
      16.2.6.2. Segmental Revenue
      16.2.6.3. Product Portfolio
      16.2.6.4. Key Developments
      16.2.6.5. Strategic Outlook
    16.2.7. Company G
      16.2.7.1. Company Overview
      16.2.7.2. Segmental Revenue
      16.2.7.3. Product Portfolio
      16.2.7.4. Key Developments
      16.2.7.5. Strategic Outlook
    16.2.8. Company H
      16.2.8.1. Company Overview
      16.2.8.2. Segmental Revenue
      16.2.8.3. Product Portfolio
      16.2.8.4. Key Developments
      16.2.8.5. Strategic Outlook
    16.2.9. Company I
      16.2.9.1. Company Overview
      16.2.9.2. Segmental Revenue
      16.2.9.3. Product Portfolio
      16.2.9.4. Key Developments
      16.2.9.5. Strategic Outlook
    16.2.10. Company J
      16.2.10.1. Company Overview
      16.2.10.2. Segmental Revenue
      16.2.10.3. Product Portfolio
      16.2.10.4. Key Developments
      16.2.10.5. Strategic Outlook
Chapter 17. Go-To-Market Strategy

Research Methodology

We follow a robust research methodology to analyze the market in order to provide our clients with qualitative and quantitative analysis which has a very low or negligible deviance. Extensive secondary research supported by primary data collection methods help us to thoroughly understand and gauge the market. We incorporate both top-down and bottom-up approach for estimating the market. The below mentioned methods are then adopted to triangulate and validate the market.

Secondary data collection and interpretation

Secondary research includes sources such as published books, articles in journals, news media and published businesses, government and international body publications, and associations. Sources also include paid databases such as Hoovers, Thomson Reuters, Passport and others. Data derived through secondary sources is further validated through primary sources. The secondary sources also include major manufacturers mapped on the basis of revenues, product portfolios, and sales channels.

Primary data collection

Primary data collection methods include conducting interviews with industry experts and various stakeholders across the supply chain, such as raw material suppliers, manufacturers, product distributors and customers. The interviews are either telephonic or face-to-face, or even a combination of both. Prevailing trends in the industry are gathered by conducting surveys. Primary interviews also help us to understand the market drivers, restraints and opportunities, along with the challenges in the market. This method helps us in validating the data gathered through secondary sources, further triangulating the data and developing it through our statistical tools. We generally conduct interviews with -

  • CEOs, Directors, and VPs
  • Sales and Marketing Managers
  • Plant Heads and Manufacturing Department Heads
  • Product Specialists

Supply Side and Demand Side Data Collection

Supply side analysis is based on the data collected from the manufacturers and the product providers in terms of their segmental revenues. Secondary sources for this type of analysis include company annual reports and publications, associations and organisations, government publications and others.

Demand side analysis is based upon the consumer insights who are the end users of the particular product in question. They could be an individual user or an organisation. Such data is gathered through consumer surveys and focused group interviews.

Market Engineering

As a primary step, in order to develop the market numbers we follow a vigorous methodology that includes studying the parent market of the niche product and understanding the industry trends, acceptance among customers of the product, challenges, future growth, and others, followed by further breaking down the market under consideration into various segments and sub-markets. Additionally, in order to cross-validate the market, we also determine the top players in the market, along with their segmental revenues for the said market. Our secondary sources help us to validate the market share of the top players. Using both the qualitative and quantitative analysis of all the possible factors helps us determine the market numbers which are inclined towards accuracy.

Request a detailed Research Methodology for the market.

Request Customization or Sample Report

To request a sample report or for any inquiry regarding this report, please fill out the form below

Yes, I have read the Privacy Policy.

Related Reports






latest reports